• Press Release

The Icahn School of Medicine at Mount Sinai Joins NeuroNEXT Research Network Through Five-Year Grant From the National Institutes of Health

Innovative network designed to increase efficiency of neuroscience clinical trials for brain disorders

  • New York, NY
  • (August 02, 2018)

The Icahn School of Medicine at Mount Sinai (ISMMS) has joined the Network for Excellence in Neuroscience Clinical Trials (NeuroNEXT), a research program that helps streamline phase II clinical trials for brain disorders.  NeuroNEXT is supported by the National Institute of Neurological Disorders and Stroke (NINDS), part of the National Institutes of Health (NIH).

“Earning a place in the NeuroNEXT network enables us to expand the collaborations taking place between basic and clinical brain researchers and experienced clinicians in numerous departments across the Mount Sinai Health System and with partners outside our institution,” says Barbara Vickrey, MD, MPH, Henry P. and Georgette Goldschmidt Professor and System Chair of Neurology.  “Through this national network, we can build upon remarkable advances that have been achieved in studying the brain and spinal cord—many developed and put into practice at Mount Sinai—so that we can take what we learn at the bench and translate that knowledge into fundamentally new and improved treatments.  We are well positioned to ensure timely, successful execution of these trials and are proud to be partnering with such an excellent cadre of research institutions that share a commitment to collaboration. Through this shared value and robust partnership, we can bring hope to the many patients and families who face devastating neurological conditions.”    

Started in 2012 to make neuroscience clinical trials more efficient and to help increase the number of treatments that get into clinical practice, the NeuroNEXT program is designed to encourage collaborations between academic centers, disease foundations, and industry.  Through this integrated network, participating academic medical centers will be able to enroll more patients in larger clinical trials and complete them more rapidly than each center could by itself. 

Aaron Miller, MD, Professor of Neurology at ISMMS and Director of Clinical Affairs for The Corinne Goldsmith Dickinson Center for Multiple Sclerosis at Mount Sinai, and Adilia Hormigo, MD, PhD, Associate Professor of Neurology, Medicine, and Neurosurgery at ISMMS and Director of the Neuro-Oncology Program at The Mount Sinai Hospital, will serve as Principal Investigators of the five-year NIH grant.  Nathalie Jette, MD, MSc, Vice Chair for Clinical Research in the Department of Neurology at ISMMS, will serve as the Career Enhancement Director for junior/early stage investigator training for NeuroNEXT projects at Mount Sinai.  The grant enables researchers from Mount Sinai to quickly mobilize with a diverse set of clinicians and experts from a wide range of disciplines to expedite clinical research so that treatments can get to patients faster.

About the Mount Sinai Health System

The Mount Sinai Health System is New York City's largest academic medical system, encompassing eight hospitals, a leading medical school, and a vast network of ambulatory practices throughout the greater New York region. Mount Sinai is a national and international source of unrivaled education, translational research and discovery, and collaborative clinical leadership ensuring that we deliver the highest quality care—from prevention to treatment of the most serious and complex human diseases. The Health System includes more than 7,200 physicians and features a robust and continually expanding network of multispecialty services, including more than 400 ambulatory practice locations throughout the five boroughs of New York City, Westchester, and Long Island. The Mount Sinai Hospital is ranked No. 14 on U.S. News & World Report's "Honor Roll" of the Top 20 Best Hospitals in the country and the Icahn School of Medicine as one of the Top 20 Best Medical Schools in country. Mount Sinai Health System hospitals are consistently ranked regionally by specialty and our physicians in the top 1% of all physicians nationally by U.S. News & World Report.

For more information, visit https://www.mountsinai.org or find Mount Sinai on FacebookTwitter and YouTube.